Urological Research

, Volume 17, Issue 6, pp 361–366 | Cite as

Urinary antibody response after immunisation with a vaccine against urinary tract infection

  • D. Kruze
  • K. Holzbecher
  • M. Andrial
  • W. Bossart
Original Articles


Immunisation of mice with SolcoUrovac® vaccine induced an approximately 10-fold increase of the total amount of IgG and a 2-fold increase of IgA immunoglobulins in urine. IgG antibodies to Solco-Urovac antigens appeared in urine after the first injection, and booster injections caused a further increase of the titer. IgA antibodies appeared in the urine after the second injection, and the third injection doubled the titer. IgM immunoglobulins and specific IgM class antibodies to Solco Urovac were not found in any urine tested. The exact origin of the immunoglobulins in the urine as well as the spcificity of immune response is discussed.

Key words

Immunisation Protection against urinary infection Urine antibodies 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brooks SJD, Lyons JM, Braude AJ (1974) Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccine. Am J Pathol 74:359–364Google Scholar
  2. 2.
    Garg UC, Ganguly NK, Sharma S, Bhatnagar R (1987) Antipiliantibody affords protection against ascending pyelonephritis in rat: evaluated by renal brush border membrane enzymes. Biochem Int 14:517–524Google Scholar
  3. 3.
    Grischke EM, Rüttgers H (1987) Treatment of bacterial infections of the female urinary tract by immunisation of the patients. Urol Int 42:338–341Google Scholar
  4. 4.
    Hand WL, Smith JW, Miller TE, Barnett JA, Sanford JP (1970) Immunoglobulin synthesis in lower urinary tract infection. J Lab Clin Med 75:19–29Google Scholar
  5. 5.
    Hand WL, Smith JW, Sanford JP (1971) The antibacterial effect of normal and infected urinary bladder. J Lab Clin Med 77:605–615Google Scholar
  6. 6.
    Kaijser B, Olling S (1973) Experimental hematogenous pyelonephritis due to E. coli in rabbits: the antibody response and its protective capacity. J Infect Dis 128:41–49Google Scholar
  7. 7.
    Kaijser B, Ahlstedt S (1977) Protective capacity of antibodies against Escherichia coli O und K antigens. Infect Immun 17:286–289Google Scholar
  8. 8.
    Kaijser B, Larsson P, Olling S (1978) Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity. Infect Immun 20:78–81Google Scholar
  9. 9.
    Källenius G, Svenson SB, Mollby R, Korhonen T, Winberg J, Cedergren B, Helin I, Hultberg H (1982) Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis [Suppl] 33:52–60Google Scholar
  10. 10.
    Kauffmann DB, Katz R, McInthosh RM (1970) Secretory IgA in urinay tract infections. Br Med J 4:463–465Google Scholar
  11. 11.
    Lehmann JD, Smith JW, Miller TE, Barnett JA, Sandford JP (1968) Local immune response in experimental pyelonephritis. J Clin Invest 47:2541–2550Google Scholar
  12. 12.
    Litschgi M (1987) Treatment of urinary infection with SolcoUrovac (in German). Geburtshilfe Frauenheilkd 2:107–110Google Scholar
  13. 13.
    Mattsby-Baltzer I, Hanson L, Olling S, Kaijser B (1982) Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli. Infect Immun 35:647–653Google Scholar
  14. 14.
    Ratner JJ, Thomas VL, Sandford BA, Forland M (1981) Bacteria-specific antibody in the urine of patients with acute pyelonephritis and cystitis. J Infect Dis 143:404–412Google Scholar
  15. 15.
    Riedasch G, Möhring K (1986) Immunotherapy of recurrent urinary infections in women (in German). Therapiewoche Schweiz 10:896–900Google Scholar
  16. 16.
    Riedasch G, Möhring K (1987) Is immunotherapy beneficial in chronic bacterial prostatitis? In: Weidner W, Brunner H, Krause W, Rothauge G (eds) Therapy of prostatitis. Zuckschwerdt, München, pp 127–131Google Scholar
  17. 17.
    Roberts JA, Hardaway K, Kaack B, Fussell EN, Baskin G (1984) Prevention of pyelonephritis by immunization with P-Fimbriae. J Urol 131:602–607Google Scholar
  18. 18.
    Rüttgers H, Grischke E (1987) Elevation of secretory IgA antibodies in the urinary tract by immunostimulation for the preoperative treatment and post-operative prevention of urinary tract infections. Urol Int 42:424–426Google Scholar
  19. 19.
    Rumans LW, Vosti KL (1977) Antibody-coated bacteria (letter). JAMA 237:531Google Scholar
  20. 20.
    Silverblatt FJ, Cohen LS (1979) Antipili antibody affords protection against experimental ascending pyelonephritis. J Clin Invest 64:333–336Google Scholar
  21. 21.
    Silverblatt FJ, Weinstein R, Rene P (1982) Protection against experimental pyelonephritis by antibodies to pili. Scand J Infect Dis [Suppl] 33:79–82Google Scholar
  22. 22.
    Smith JW, Wagner S, Swenson RM (1981) Local immune response to E. coli pili in experimental pyelonephritis. Infect Immun 31:17–20Google Scholar
  23. 23.
    Sohl-Akerlund A, Ahlstedt S, Hanson LA, Jodal U (1979) Antibody responses in urine and serum against Escherichia coli O antigen in childhood urinary tract infection. Acta Pathol Microbiol Scand 87:29–36Google Scholar
  24. 24.
    Svanborg Eden C, Fasth A, Jodal U (1982) Immunology of urinary tract infection. In: Reevesand DS, Geddes AM (eds) Recent advances in infection. Churchill Livingstone, Edinburgh, pp 141–162Google Scholar
  25. 25.
    Thomas V, Shelokov A, Forland M (1974) Antibody-coated bacteria in the urine and the site of urinary-tract infection. N Engl J Med 290:588–590Google Scholar
  26. 26.
    Uehling DT, Stiehm RM (1971) Elevated urinary secretory IgA in children with urinary tract infection. Paediatrics 47:40–46Google Scholar
  27. 27.
    Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC (1982) A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146:719–723Google Scholar
  28. 28.
    Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL Jr (1987) Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis 155:1151–1158Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • D. Kruze
    • 1
  • K. Holzbecher
    • 1
  • M. Andrial
    • 1
  • W. Bossart
    • 1
  1. 1.Research and Development DepartmentSolco Basle Ltd.BasleSwitzerland

Personalised recommendations